Morphine and dipyrone co-administration delays tolerance development and potentiates antinociception

被引:26
作者
Hernández-Delgadillo, GP [1 ]
López-Muñoz, FJ [1 ]
Salazar, LA [1 ]
Cruz, SL [1 ]
Cruz, L [1 ]
机构
[1] IPN, CINVESTAV, Dept Farmacol, Mexico City 14330, DF, Mexico
关键词
opioid; metamizol; antinociception; potentiation; tolerance;
D O I
10.1016/S0014-2999(03)01727-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work analyses the time course of tolerance development and antinociceptive potentiation throughout repeated co-administration of morphine (an opioid receptor agonist) plus dipyrone (a non-steroidal anti-inflammatory drug) in the tail-flick test. Male Wistar rats were i.v. injected with morphine (3.1 mg/kg), dipyrone (600 mg/kg) or the combination morphine/dipyrone twice a day for 5 days. Dipyrone produced antinociceptive effects with a trend towards tolerance development at the end of the treatment. Morphine was initially effective, but complete tolerance developed after its fifth administration. The combination of morphine plus dipyrone produced a significant potentiation and longer duration of antinociceptive effects. The antinociceptive efficacy of morphine and dipyrone co-administration gradually decreased after the sixth injection. An additional group of rats treated with dipyrone for 11 days developed complete tolerance after the 19th administration. These data suggest that repeated co-administration of morphine plus dipyrone results in a delay of tolerance development and in a potentiation of their individual antinociceptive effects. (C) 2003 Elsevier Science B.V All rights reserved.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 56 条
[1]   Evidence for a peripheral mechanism of action for the potentiation of the antinociceptive effect of morphine by dipyrone [J].
Aguirre-Bañuelos, P ;
Granados-Soto, V .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1999, 42 (02) :79-85
[2]   A possible central antinociceptive effect of dipyrone in mice [J].
Akman, H ;
Aksu, F ;
Gultekin, I ;
Ozbek, H ;
Oral, U ;
Doran, F ;
Baysal, F .
PHARMACOLOGY, 1996, 53 (02) :71-78
[3]   The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats [J].
Allen, RM ;
Dykstra, LA .
PSYCHOPHARMACOLOGY, 1999, 142 (02) :209-214
[4]  
[Anonymous], 2001, Goodman Gilman's
[5]   Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action [J].
Beirith, A ;
Santos, ARS ;
Rodrigues, ALS ;
Creczynski-Pasa, TB ;
Calixto, JB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 345 (03) :233-245
[6]   THE ADDITIVE ANALGESIC EFFICACY OF ACETAMINOPHEN, 1000 MG, AND CODEINE, 60 MG, IN DENTAL PAIN [J].
BENTLEY, KC ;
HEAD, TW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (06) :634-640
[7]  
BHARGAVA HN, 1994, PHARMACOL REV, V46, P293
[8]   CENTRAL, NALOXONE-REVERSIBLE ANTINOCICEPTION BY DICLOFENAC IN THE RAT [J].
BJORKMAN, R ;
HEDNER, J ;
HEDNER, T ;
HENNING, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1990, 342 (02) :171-176
[9]  
CALIMLIM JF, 1976, CLIN PHARMACOL THER, V21, P34
[10]   Regulation of cyclooxygenase activity by metamizol [J].
Campos, C ;
de Gregorio, R ;
García-Nieto, R ;
Gago, F ;
Ortiz, P ;
Alemany, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 378 (03) :339-347